Concepedia

Publication | Open Access

Clinical impact of amyloid PET using 18F-florbetapir in patients with cognitive impairment and suspected Alzheimer’s disease: a multicenter study

DOIFull Paper Access

27

Citations

33

References

2022

Year

Hiroshi Matsuda, Kyoji Okita, Yumiko Motoi, Toshiki Mizuno, Manabu Ikeda, Nobuo Sanjo, Koji Murakami, Taiki Kambe, Toshiki Takayama, Kei Yamada,
Annals of Nuclear Medicine

Abstract

Amyloid PET using <sup>18</sup>F-florbetapir PET had a substantial clinical impact on AD and non-AD diagnosis and on patient management by enhancing diagnostic confidence. In addition, the quantitative measures may improve the visual interpretation of amyloid positivity.

References

YearCitations

Page 1